Muzaffar H. Qazilbash, MD, on Multiple Myeloma: Results From a Treatment Trial

Posted: Monday, December 11, 2017

Muzaffar H. Qazilbash, MD, of The University of Texas MD Anderson Cancer Center, discusses phase III study findings on busulfan plus melphalan vs melphalan alone for patients with multiple myeloma.